Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in a Preclinical Model By Monoclonal Anti-HPA-1a Antibody Prophylaxis: Structural and Functional Properties of Antibody Variant Isoforms

Trude Victoria Mørtberg, Huiying Zhi, Gestur Vidarsson, Stian Foss, Terje E Michaelsen, Bjørn Skogen, Tor Brynjar Stuge, Jan Terje Andersen, Peter J. Newman, Maria Therese Ahlen

Blood (2021) 138 (Supplement 1): 1011.

https://doi.org/10.1182/blood-2021-149196

Published: 2021

Journal Articles

An Authentic Murine Model of Fetal/Neonatal Alloimmune Thrombocytopenia

Huiying Zhi, PhD, Maria Therese Ahlen, PhD, Trude Rasmussen, Bjørn Skogen, MD, Peter J. Newman, PhD

Blood (2019) 134 (Supplement_1): 97.

https://doi.org/10.1182/blood-2019-130573

Published: 2019

Journal Articles

Atomic-Level Dissection of the Polyclonal Immune Response to the Human Platelet Alloantigen, HPA-1a (Pl A1 )

Huiying Zhi, PhD, Maria Therese Ahlen, PhD, Aye Myat Myat Thinn, PhD, Hartmut Weiler, PhD, Brian R. Curtis, PhD, Bjorn Skogen, MD, Jieqing Zhu, PhD, Peter Newman, PhD

Blood (2018) 132 (Supplement 1): 1258.

https://doi.org/10.1182/blood-2018-99-111327

Published: 2018

Journal Articles

Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a

Huiying Zhi, PhD, Maria Therese Ahlen, PhD, Bjørn Skogen, PhD, Peter Newman, PhD

Blood (2017) 130 (Supplement 1): 764.

https://doi.org/10.1182/blood.V130.Suppl_1.764.764

Published: 2017

Journal Articles

Platelet antibody identification: toward a solution

Bjørn Skogen

Blood (2016) 127 (6): 665–666.

https://doi.org/10.1182/blood-2015-12-686634

Published: 2016

Journal Articles

Maternal Anti-Platelet β3 Integrin Antibodies Impair Angiogenesis and Cause Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia

Blood (2014) 124 (21): 2772.

https://doi.org/10.1182/blood.V124.21.2772.2772

Published: 2014

Journal Articles

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

Rick Kapur, Iwan Kustiawan, Anne Vestrheim, Carolien A. M. Koeleman, Remco Visser, Helga K. Einarsdottir, Leendert Porcelijn, Dave Jackson, Belinda Kumpel, André M. Deelder, Dennis Blank, Björn Skogen, Mette Kjaer Killie, Terje E. Michaelsen, Masja de Haas, Theo Rispens, C. Ellen van der Schoot, Manfred Wuhrer, Gestur Vidarsson

Blood (2014) 123 (4): 471–480.

https://doi.org/10.1182/blood-2013-09-527978

Published: 2014

Includes: Supplemental data

Journal Articles

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data

Jens Kjeldsen-Kragh, Anne Husebekk, Mette Kjær Killie, Bjørn Skogen

Blood (2011) 118 (9): 2638–2639.

https://doi.org/10.1182/blood-2011-06-360404

Published: 2011

Journal Articles

Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn.

Heidi Tiller, Mette Kjaer Killie, Anne Husebekk, Bjorn Skogen, Heyu Ni, Jens Kjeldsen-Kragh, Paal Oian

Blood (2009) 114 (22): 2405.

https://doi.org/10.1182/blood.V114.22.2405.2405

Published: 2009

Journal Articles

Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model.

Heidi Tiller, Pingguo Chen, Bjorn Skogen, Mette Kjaer Killie, Anne Husebekk, Maryana Matviyenko, Jens Kjeldsen-Kragh, Heyu Ni

Blood (2009) 114 (22): 223.

https://doi.org/10.1182/blood.V114.22.223.223

Published: 2009

Journal Articles

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4 + T cells

Maria Therese Ahlen, Anne Husebekk, Mette Kjær Killie, Bjørn Skogen, Tor B. Stuge

Blood (2009) 113 (16): 3838–3844.

https://doi.org/10.1182/blood-2008-09-178475

Published: 2009

Journal Articles

Isolation and Characterization of CD4 + T Cells Specific for the HPA 1a Epitope Associated with Neonatal Alloimmune Thrombocytopenia.

Maria T. Ahlen, Mette K. Killie, Bjorn Skogen, Anne Husebekk, Tor B. Stuge

Blood (2007) 110 (11): 2091.

https://doi.org/10.1182/blood.V110.11.2091.2091

Published: 2007

Journal Articles

The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type.

Maria T. Ahlen, Mette K. Killie, Anne Husebekk, Jens Kjeldsen-Kragh, Martin L. Olsson, Bjorn Skogen

Blood (2007) 110 (11): 2093.

https://doi.org/10.1182/blood.V110.11.2093.2093

Published: 2007

Journal Articles

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia

Jens Kjeldsen-Kragh, Mette Kjær Killie, Geir Tomter, Elzbieta Golebiowska, Ingrid Randen, Reidun Hauge, Berit Aune, Pål Øian, Lauritz B. Dahl, Jouko Pirhonen, Rolf Lindeman, Henrik Husby, Guttorm Haugen, Morten Grønn, Bjørn Skogen, Anne Husebekk

Blood (2007) 110 (3): 833–839.

https://doi.org/10.1182/blood-2006-08-040121

Published: 2007

Journal Articles

A Screening and Intervention Program Reducing Mortality and Serious Morbidity Associated with Neonatal Alloimmune Thrombocytopenia.

Jens Kjeldsen-Kragh, MD, PhD, Mette K. Killie, MSc, Geir Tomter, MT, Elzbieta Golebiowska, MT, Helene Pedersen, MT, Ingrid Randen, PhD, Reidun Hauge, MT, Berit Aune, MD/PhD, Pal Oian, MD/PhD, Lauritz B. Dahl, MD/PhD, Jouko Pirhonen, MD/PhD, Leif Svenningsen, MD/PhD, Hakon Wergeland, MD, Rolf Lindeman, MD/PhD, Henrik Husby, MD, Morten Gronn, MD/PhD, Bjorn Skogen, MD/PhD, Anne Husebekk, MD/PhD

Blood (2005) 106 (11): 1232.

https://doi.org/10.1182/blood.V106.11.1232.1232

Published: 2005

Journal Articles

Quantitative Analyses of BCR-ABL Mutations Associated with Imatinib Treatment in CML.

Franz Gruber, MD, Henrik Hjort Hansen, MD, Marita Olsen, Lab.tech., Lene Eggen, Lab.tech., Bjørn Skogen, MD, Tobias Gedde-Dahl, MD, Tuija Lundan, MD, Kimmo Porkka, MD, Bengt Simonsson, MD, Berit Markevärn, MD, Hans Wadenvik, MD, Leif Stenke, MD

Blood (2005) 106 (11): 2000.

https://doi.org/10.1182/blood.V106.11.2000.2000

Published: 2005

Journal Articles

Maternal Anti-HPA1a Antibody Level as Predictive Value in Neonatal Alloimmune Trombocytopenic Purpura (NAITP).

Mette K. Killie, M.Sc, Jens Kjeldsen-Kragh, MD, PhD, Bjørn Skogen, MD, PhD, Anne Husebekk, MD, PhD

Blood (2004) 104 (11): 2072.

https://doi.org/10.1182/blood.V104.11.2072.2072

Published: 2004

NARROW

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in a Preclinical Model By Monoclonal Anti-HPA-1a Antibody Prophylaxis: Structural and Functional Properties of Antibody Variant Isoforms

An Authentic Murine Model of Fetal/Neonatal Alloimmune Thrombocytopenia

Atomic-Level Dissection of the Polyclonal Immune Response to the Human Platelet Alloantigen, HPA-1a (Pl A1 )

Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a

Platelet antibody identification: toward a solution

Maternal Anti-Platelet β3 Integrin Antibodies Impair Angiogenesis and Cause Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data

Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn.

Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model.

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4 + T cells

Isolation and Characterization of CD4 + T Cells Specific for the HPA 1a Epitope Associated with Neonatal Alloimmune Thrombocytopenia.

The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type.

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia

A Screening and Intervention Program Reducing Mortality and Serious Morbidity Associated with Neonatal Alloimmune Thrombocytopenia.

Quantitative Analyses of BCR-ABL Mutations Associated with Imatinib Treatment in CML.

Maternal Anti-HPA1a Antibody Level as Predictive Value in Neonatal Alloimmune Trombocytopenic Purpura (NAITP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only